Go to the list of all blogs
Alicia's Avatar
published in Blogs
Apr 22, 2026
Why Is Sportradar Group (SRAD) Stock Down -22% Today?

Why Is Sportradar Group (SRAD) Stock Down -22% Today?

Key Takeaways

  • Shares of SRAD are plunging approximately 22% in Wednesday's session on April 22, 2026, declining from a prior close of $16.84 to approximately $13.13, as investors react to a combination of weaker-than-expected full-year 2025 financial results and a downward revision to the company's 2026 organic growth outlook.

  • The primary catalyst is the April 21 release of Sportradar's Q4 and full-year 2025 earnings, which showed revenue falling modestly short of analyst consensus estimates due to significant foreign exchange headwinds — an increasingly critical variable for the Swiss-headquartered company generating revenue across dozens of currencies.

  • 2026 organic growth rate guidance was revised downward, reflecting ongoing concerns about currency conversion impacts and broader macroeconomic conditions that are weighing on the sports betting technology ecosystem.

  • Truist Securities lowered its price target on SRAD from $32 to $26 on April 21, maintaining a Buy rating — the third analyst target reduction in recent months — reinforcing a sustained narrative of earnings deceleration.

  • The stock has now declined approximately 58.7% from its 52-week high of $32.22, and Wednesday's selloff pushes SRAD toward its 52-week low of $14.70.

  • Traders will focus on the Q1 2026 earnings release scheduled for May 6, 2026, and whether management can demonstrate stabilization in FX-adjusted revenue trends.

Opening Summary

Sportradar Group AG (SRAD) is a St. Gallen, Switzerland-based global sports technology company and the world's leading B2B provider of sports data, analytics, and technology platforms, serving the sports betting, media, and sports federation markets across more than 120 countries. The company collects, processes, and distributes real-time sports data — powering odds compilation, live streaming, integrity services, and fan engagement products for major customers including global sportsbooks, broadcasters, and leagues. Shares are declining approximately 22% on Wednesday, April 22, 2026, falling from a prior close of $16.84 to approximately $13.13 in heavy volume trading. The selloff is a direct earnings-driven market reaction to the company's Q4 and full-year 2025 results, released April 21, which missed consensus revenue estimates on foreign exchange headwinds and included a downward revision to the 2026 organic growth outlook.

Q4 and Full-Year 2025 Earnings Disappoint

The definitive catalyst for today's 22% price decline is the market's full post-earnings digestion of Sportradar's Q4 and full-year 2025 financial results, released after the close on April 21. Revenue came in modestly below analyst consensus estimates, with the shortfall attributed primarily to unfavorable foreign currency translation effects — a structural challenge for a company that generates a substantial portion of its revenue in euros, British pounds, and other non-dollar currencies but reports in USD. The 2026 organic growth rate guidance was revised downward from prior expectations, with management citing worsening currency conversion impacts and broader macroeconomic uncertainty as headwinds to the near-term top-line trajectory. For a stock that had already been heavily sold over the preceding 12 months — down 32.7% year-over-year — the absence of a positive earnings inflection point removes the key catalyst needed to stabilize investor confidence and triggers another leg of institutional selling.

Analyst Price Target Reductions Reinforce Bearish Momentum

The earnings-driven selloff is amplified by the sustained pattern of analyst price target reductions that has characterized SRAD coverage over the past several months. Truist Securities lowered its price target from $32 to $26 on April 21 while maintaining a Buy rating — a reduction of 18.75% in the target that signals declining earnings confidence even among the stock's most constructive institutional analysts. Morgan Stanley maintained an Equal-Weight rating with a $25 target, while Wells Fargo previously cut to $24 from $26 in early March 2026. The convergence of these target reductions toward the $24–$26 range — now well above today's trading level near $13 — reflects how quickly the earnings deceleration has outpaced analyst model revisions. With 19 Buy and 2 Hold ratings from 24 covering analysts, the formal institutional consensus remains constructive, but the gap between analyst targets and actual trading price is a persistent source of credibility pressure on those recommendations.

FX Headwinds and the Structural Revenue Challenge

A recurring and structurally important driver of SRAD's earnings trajectory is the foreign exchange translation impact on its reported USD results. As a Swiss company operating across the European sports betting market — where a significant portion of customer contracts are denominated in euros and sterling — Sportradar is directly exposed to U.S. dollar strengthening. The dollar's appreciation against major currencies in the first quarter of 2026 translated to meaningful top-line compression when results are converted to USD for reporting. Combined with macroeconomic headwinds affecting consumer-facing sportsbook spending in key European markets, the FX impact has made it structurally difficult for Sportradar to beat USD-denominated revenue consensus estimates in the current rate environment. This dynamic is unlikely to resolve quickly, given that the Federal Reserve's rate path and the dollar's trajectory remain uncertain heading into the second half of 2026.

Market Context and Trading Activity

Volume in SRAD on April 22 is tracking substantially above its 30-day average of approximately 2.69 million shares, confirming a high-conviction institutional repositioning event. The iShares Expanded Tech-Software Sector ETF (IGV) and broader technology sector ETFs are under moderate pressure Wednesday, but SRAD's decline is dramatically larger than the sector average, confirming that the selloff is earnings-driven rather than macro-driven. Technically, SRAD has broken decisively below the $15.50 support level identified by multiple technical analysts and is now approaching the 52-week low of $14.70 — with today's trading near $13.13 representing a potential new 52-week low if sustained through the close. The stock's 200-day simple moving average sits well above current price levels, confirming an extended technical downtrend.

Trending AI Robots

For traders navigating sharp earnings-driven selloffs in global sports technology stocks like today's decline in SRAD, Tickeron's Trending AI Robots page provides a curated view of the platform's strongest-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers, but only those demonstrating the highest real-time performance are featured in this section. Bots span a wide range of strategy types, holding timeframes, risk profiles, performance metrics, and the universe of symbols they trade — from mean-reversion systems designed for post-earnings dislocations to longer-timeframe systematic strategies built for technology sector equities. Whether you are managing exposure following sharp earnings-driven price drops or identifying structured opportunities across the broader market, the Trending AI Robots page is a practical starting point for AI-assisted trading.

What Comes Next for SRAD

The next critical event for SRAD is the Q1 2026 earnings release on May 6, 2026, accompanied by a management webcast at 8:30 a.m. ET. This print will be the first opportunity for Sportradar's leadership team to address investor concerns about the 2026 organic growth deceleration, provide an updated FX sensitivity framework, and clarify the cadence of revenue recognition from new long-term contracts — including the company's expanded partnerships with the NBA, NFL, and major European football leagues. Investors will scrutinize whether the Q1 revenue growth rate on an FX-neutral basis is holding to management's projections and whether the $1 billion share buyback program announced in March 2026 will be deployed aggressively to support the stock at depressed levels. Key risks include further USD strengthening compressing reported revenues, slowing growth in U.S. online sports betting handle as market saturation increases in established states, competitive pressure from in-house data capabilities being developed by major sportsbooks, and the possibility of further analyst estimate reductions if Q1 2026 results disappoint.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SRAD

Contributor

Alicia's AvatarAlicia|Beginner

SRAD in -2.90% downward trend, declining for three consecutive days on September 08, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SRAD declined for three days, in 225 of 277 cases, the price declined further within the following month. The odds of a continued downward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for SRAD entered a downward trend on August 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 56 cases where SRAD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Momentum Indicator moved above the 0 level on September 11, 2026. You may want to consider a long position or call options on SRAD as a result. In 71 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for SRAD just turned positive on September 02, 2026. Looking at past instances where SRAD's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.

Following a +6.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRAD advanced for three days, in 221 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. SRAD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.193) is normal, around the industry mean (28.425). P/E Ratio (221.777) is within average values for comparable stocks, (75.656). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.599). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (2.542) is also within normal values, averaging (78.066).

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRAD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Atlassian Corp (NASDAQ:TEAM), Workday (NASDAQ:WDAY), Autodesk (NASDAQ:ADSK).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.02B. The market cap for tickers in the group ranges from 291 to 238.27B. SAP holds the highest valuation in this group at 238.27B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -4%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 3%. FTFT experienced the highest price growth at 77%, while AIXI experienced the biggest fall at -88%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 60
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
SRAD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Details
Industry
N/A
Address
Feldlistrasse 2
Phone
+41 715177200
Employees
4882
Web
https://www.sportradar.com
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.